Andy Chi
Impact in
-
- Lymphoma Diagnosis and Treatment
- Oncology top 10%
- Viral-associated cancers and disorders
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
Papers in
-
- Lymphoma Diagnosis and Treatment 6
-
- Statistical Methods in Clinical Trials 3
- Advanced Causal Inference Techniques 2
- Co-authors
- Dirk Huebner (5 shared papers)John William Sweetenham (1 shared paper)Patrick J. Stiff (1 shared paper)Jan Andrzej Walewski (1 shared paper)Veronika Bachanová (1 shared paper)Dzhelil Osmanov (1 shared paper)Muneer Hyder Abidi (1 shared paper)Eric L. Sievers (1 shared paper)
- Journals
- Critical Reviews in Oncology/Hematology (2 papers)Current Medical Research and Opinion (2 papers)Journal of the American Podiatric Medical Association (1 paper)Contemporary Clinical Trials (1 paper)Journal of Biopharmaceutical Statistics (1 paper)
- Partner nations
- United StatesItalyJapan
In The Last Decade
Andy Chi
9 papers receiving 678 citations
Andy Chi's Hit Papers
Peers
Comparison fields: 5 of 51
- Pathology and Forensic Medicine 473
- Oncology 377
- Neurology 179
- Genetics 104
- Dermatology 88
Countries citing papers authored by Andy Chi
This map shows the geographic impact of Andy Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Chi more than expected).
Fields of papers citing papers by Andy Chi
This network shows the impact of papers produced by Andy Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Chi. The network helps show where Andy Chi may publish in the future.
Co-authors
The 25 scholars most cited alongside Andy Chi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2015 | 573 |
| 2 | 2016 | 44 | |
| 3 | 2016 | 28 | |
| 4 | 2020 | 20 | |
| 5 | 2015 | 15 | |
| 6 | 2015 | 9 | |
| 7 | 2024 | 2 | |
| 8 | 2021 | 2 | |
| 9 | 2011 | 1 | |
| 10 | 2012 | 1 |
About Andy Chi
Andy Chi is a scholar working on Pathology and Forensic Medicine, Statistics and Probability, Dermatology, Immunology and Rehabilitation, having authored 10 papers that have together received 695 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Statistical Methods in Clinical Trials (3 papers), Cutaneous lymphoproliferative disorders research (2 papers), Advanced Causal Inference Techniques (2 papers), T-cell and Retrovirus Studies (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Musculoskeletal Disorders and Rehabilitation (1 paper) and Advanced Radiotherapy Techniques (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (473 citations), Oncology (377 citations), Neurology (179 citations), Genetics (104 citations) and Dermatology (88 citations). Andy Chi has collaborated with scholars based in United States, Italy and Japan. Frequent co-authors include Dirk Huebner, John William Sweetenham, Patrick J. Stiff, Jan Andrzej Walewski, Veronika Bachanová, Dzhelil Osmanov, Muneer Hyder Abidi, Eric L. Sievers, Tamás Masszi and Andy I. Chen. Their work appears in journals such as Critical Reviews in Oncology/Hematology, Current Medical Research and Opinion, Journal of the American Podiatric Medical Association, Contemporary Clinical Trials and Journal of Biopharmaceutical Statistics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.